Literature DB >> 16365357

Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children.

M J Fenton1, H Chubb, A M McMahon, P Rees, M J Elliott, M Burch.   

Abstract

OBJECTIVE: To review the outcome of cardiac transplantation for restrictive cardiomyopathy (RCM) in children and to assess the ability of new strategies to modulate the effects of high pulmonary vascular resistance.
DESIGN: Retrospective case note analysis of all patients receiving a transplant for RCM. PATIENTS: 18 children with RCM referred for transplantation assessment to Great Ormond Street Hospital, London.
RESULTS: Eight boys and 10 girls were referred for assessment. Median age at presentation was 5.0 (mean (SD) 6.1 (4.0)) years. Fourteen orthotopic and two heterotopic transplantations were performed and two patients were referred for heart-lung transplantation. Mean duration from diagnosis to transplantation was 3.3 (3.0) years. Three patients with haemodynamic decompensation before transplantation had increased morbidity in the postoperative period. No patients died while awaiting a transplant. Three patients died in the first year after transplantation, one within 30 days. Five patients received pre-transplantation prostacyclin for a mean duration of 57 (18) days. Transpulmonary gradient was reduced in four of the patients. Mean transpulmonary gradient was 27 (9.8) mm Hg before and 17 (6.7) mm Hg after treatment with prostacyclin (p < 0.05).
CONCLUSION: Most children with RCM require transplantation within four years of diagnosis. Referral for transplantation assessment should precede haemodynamic decompensation. Increase of pulmonary vascular resistance is a variable problem but can be modulated with pre-transplantation prostacyclin. With these strategies, orthotopic transplantation is possible in the majority of cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365357      PMCID: PMC1860993          DOI: 10.1136/hrt.2004.049502

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

Review 1.  Sudden death in children with restrictive cardiomyopathy.

Authors:  Susan W Denfield
Journal:  Card Electrophysiol Rev       Date:  2002-02

2.  Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy.

Authors:  M L Hughes; S Kleinert; A Keogh; P Macdonald; J L Wilkinson; R G Weintraub
Journal:  J Heart Lung Transplant       Date:  2000-07       Impact factor: 10.247

3.  The Registry of the International Society for Heart and Lung Transplantation: Sixth Official Pediatric Report--2003.

Authors:  Mark M Boucek; Leah B Edwards; Berkeley M Keck; Elbert P Trulock; David O Taylor; Paul J Mohacsi; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2003-06       Impact factor: 10.247

4.  Idiopathic restrictive cardiomyopathy in the young: report of two cases.

Authors:  C Rapezzi; P Ortolani; G Binetti; F M Picchio; B Magnani
Journal:  Int J Cardiol       Date:  1990-11       Impact factor: 4.164

5.  Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome.

Authors:  Matthew T Kimberling; David T Balzer; Russel Hirsch; Eric Mendeloff; Charles B Huddleston; Charles E Canter
Journal:  J Heart Lung Transplant       Date:  2002-04       Impact factor: 10.247

6.  Optimal timing of pediatric heart transplantation.

Authors:  L J Addonizio; D T Hsu; L Fuzesi; C R Smith; E A Rose
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

7.  [Heterotropic heart transplantation in young patients with elevated pulmonary vascular resistance].

Authors:  A Gamba; R Fiocchi; F Mamprin; M Senni
Journal:  G Ital Cardiol       Date:  1999-08

8.  The incidence of pediatric cardiomyopathy in two regions of the United States.

Authors:  Steven E Lipshultz; Lynn A Sleeper; Jeffrey A Towbin; April M Lowe; E John Orav; Gerald F Cox; Paul R Lurie; Kristina L McCoy; Melissa A McDonald; Jane E Messere; Steven D Colan
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  The epidemiology of childhood cardiomyopathy in Australia.

Authors:  Alan W Nugent; Piers E F Daubeney; Patty Chondros; John B Carlin; Michael Cheung; Lynette C Wilkinson; Andrew M Davis; Stephen G Kahler; C W Chow; James L Wilkinson; Robert G Weintraub
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

10.  Outcome of idiopathic restrictive cardiomyopathy in children.

Authors:  Rachel J Weller; Robert Weintraub; Linda J Addonizio; Maryanne R K Chrisant; Welton M Gersony; Daphne T Hsu
Journal:  Am J Cardiol       Date:  2002-09-01       Impact factor: 2.778

View more
  9 in total

Review 1.  Understanding chronic heart failure.

Authors:  Matthew Fenton; Michael Burch
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

Review 2.  Cardiomyopathy: an overview.

Authors:  Randell K Wexler; Terry Elton; Adam Pleister; David Feldman
Journal:  Am Fam Physician       Date:  2009-05-01       Impact factor: 3.292

Review 3.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

Review 4.  Clinical Characteristics and Treatment of Cardiomyopathies in Children.

Authors:  Jack F Price; Aamir Jeewa; Susan W Denfield
Journal:  Curr Cardiol Rev       Date:  2016

5.  Acute Ischemic Pediatric Stroke Management: An Extended Window for Mechanical Thrombectomy?

Authors:  Ashish Kulhari; Elizabeth Dorn; Jonathan Pace; Vilakshan Alambyan; Stephanie Chen; Osmond C Wu; Macym Rizvi; Anthony Hammond; Ciro Ramos-Estebanez
Journal:  Front Neurol       Date:  2017-11-29       Impact factor: 4.003

Review 6.  Pediatric Restrictive Cardiomyopathies.

Authors:  Raffaello Ditaranto; Angelo Giuseppe Caponetti; Valentina Ferrara; Vanda Parisi; Matteo Minnucci; Chiara Chiti; Riccardo Baldassarre; Federico Di Nicola; Simone Bonetti; Tammam Hasan; Luciano Potena; Nazzareno Galiè; Luca Ragni; Elena Biagini
Journal:  Front Pediatr       Date:  2022-01-25       Impact factor: 3.418

7.  Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene.

Authors:  Yan Chen; Shiwei Yang; Jun Li; Gannan Wang; Yuming Qin; Daowu Wang; Kejiang Cao
Journal:  J Biomed Res       Date:  2013-04-20

8.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease.

Authors:  Waleed Alhabeeb; Majdy M Idrees; Stefano Ghio; Tarek Kashour
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

9.  Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy.

Authors:  Hung-Chun Yu; Curtis R Coughlin; Elizabeth A Geiger; Blake J Salvador; Ellen R Elias; Jean L Cavanaugh; Kathryn C Chatfield; Shelley D Miyamoto; Tamim H Shaikh
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.